tirzepatide inkafarma FDA Grants a New Indication for Obesity Management lose 15 FDA approval for Zepbound (tirzepatide)

, ,

During this visit, youll discuss your medical history, current health concerns, and weight loss goals

Collaborative care involving psychiatry, endocrinology, and obesity medicine specialists optimizes outcomes in these complex cases

J Bacteriol (2006) 188(5):197986.10.1128/JB.188.5.1979-1986.2006 204 SonneDPHansenMKnopFK

The most common side effects of Zepbound include gastrointestinal (GI) issues like nausea, vomiting, diarrhea, and constipation

However, important safety considerations include: Avoid use if you or your family have a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2)